Similar articles

• Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.

  Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD, Rapoport JL. Castellanos FX, et al. J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):589-96. doi: 10.1097/00004583-199705000-00008. J Am Acad Child Adolesc Psychiatry. 1997. PMID: 9136492 Clinical Trial.
• The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

  Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB. Singer HS, et al. Pediatrics. 1995 Jan;95(1):74-81. Pediatrics. 1995. PMID: 7770313 Clinical Trial.
• Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.

  Gadow KD, Sverd J. Gadow KD, et al. J Dev Behav Pediatr. 1990 Oct;11(5):269-71; discussion 272. J Dev Behav Pediatr. 1990. PMID: 1979565 Review. No abstract available.
• Tourette's syndrome: are stimulants safe?

  Kurlan R. Kurlan R. Curr Neurol Neurosci Rep. 2003 Jul;3(4):285-8. doi: 10.1007/s11910-003-0004-2. Curr Neurol Neurosci Rep. 2003. PMID: 12930697 Review.
• The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.

  Dillon DC, Salzman IJ, Schulsinger DA. Dillon DC, et al. J Clin Psychiatry. 1985 Aug;46(8):348-9. J Clin Psychiatry. 1985. PMID: 2862138